[1]
Dando, E.E. and Anvekar, R.A. 2017. Psoriasis Therapies and the Risk of Cutaneous Malignancy. SKIN The Journal of Cutaneous Medicine. 1, 2 (Aug. 2017), 55–63. DOI:https://doi.org/10.25251/skin.1.2.1.